Search for: "Dennis Crouch"
Results 341 - 360
of 2,563
Sorted by Relevance
|
Sort by Date
15 Jan 2025, 3:30 am
by Dennis Crouch A new petition for certiorari filed by Provisur Technologies challenges the Federal Circuit's approach to reviewing jury verdicts in patent cases, particularly regarding willful infringement findings. [read post]
11 Sep 2024, 6:35 pm
by Dennis Crouch On September 11, 2024, the Federal Circuit issued three separate orders denying petitions for writs of mandamus related to venue transfer decisions. [read post]
26 Dec 2023, 6:40 pm
And at his “Patently-O” blog, Dennis Crouch has a post titled “Emergency Appeal of the Apple Watch Ban. [read post]
15 Nov 2024, 8:09 am
by Dennis Crouch Recent patent prosecution data reveals a striking trend: the percentage of utility patents containing "non-transitory" software claims continued to increase -- from virtually zero 15 years ago to nearly 22% in 2024. [read post]
28 May 2023, 9:35 am
Dennis Crouch: "I just talked to a partner at a big firm who has received memos with fake case cites from at least two different associates. [read post]
29 Oct 2021, 10:18 am
I was testing out westlaw's "atleast#" search function and ended up with this chart on how often the Federal Circuit uses the term "patent" in its patent-focused decisions. pic.twitter.com/M6RuVk2fZJ — Dennis Crouch (@patentlyo) October 29, 2021 For these numbers, I aggregated all opinions filed with each decision. [read post]
24 Sep 2024, 2:32 pm
by Dennis Crouch In a nonprecedential opinion, the Federal Circuit affirmed the PTAB decision finding all claims of Novartis's U.S. [read post]
12 Jan 2025, 12:15 pm
Dennis Crouch In a newly filed petition for certiorari, DISH Network has asked the Supreme Court to resolve two important questions about attorney fee awards in patent cases: whether district courts can (1) make plaintiff's attorneys jointly liable for fee awards in exceptional cases and (2) award fees incurred during parallel Inter Partes Review (IPR) proceedings. [read post]
4 Feb 2015, 8:30 pm
" And at "Patently-O," Dennis Crouch has a post titled "Patentee Loses First IPR Appeal on all Grounds. [read post]
19 Apr 2023, 10:38 am
As Dennis Crouch of the “Patently-O” blog noted on Twitter, Judge Newman was a panelist on the closing panel of last week’s Fordham IP Conference, and she speaks at 4:46 mark of this video of that panel. [read post]
23 Dec 2015, 1:35 pm
Dennis Crouch has a useful rundown of the various opinions in the case. [read post]
14 Dec 2024, 4:25 pm
by Dennis Crouch BBiTV has signaled its intent to seek Supreme Court review of the Federal Circuit's rejection of its electronic program guide patents, teeing up important questions about patent eligibility for software innovations. [read post]
17 Dec 2024, 10:39 am
by Dennis Crouch In Palo Alto Networks, Inc. v. [read post]
14 Oct 2024, 8:52 am
by Dennis Crouch The USPTO has issued final rules aimed at expanding opportunities for practitioners to appear before the Patent Trial and Appeal Board (PTAB). [read post]
21 Jun 2018, 7:34 am
by Dennis Crouch Important non-patent Supreme Court case for businesses operating online: South Dakota v. [read post]
12 Jul 2021, 3:53 am
by Dennis Crouch In re Uber Technologies, Inc. [read post]
8 Nov 2019, 2:19 pm
by Dennis Crouch The chart above shows that the trend is continuing — more inventors per patent application. [read post]
25 Nov 2024, 4:52 pm
by Dennis Crouch The USPTO's position within the Department of Commerce means that Commerce Secretary nominees warrant careful attention from the patent community. [read post]
20 Jan 2025, 4:45 pm
by Dennis Crouch Just after President Trump spoke the oath of office, Coke Morgan Stewart was also sworn in as Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO on January 20, 2025. [read post]
10 Jan 2025, 5:45 pm
by Dennis Crouch In an important opinion exploring the relationship between patent validity and after-arising technology, the Federal Circuit has reversed a district court's invalidation of a pharmaceutical patent covering Novartis's blockbuster heart failure drug Entresto. [read post]
